how AI and protein folding are opening new therapeutic opportunities
Drug discovery has long been a slow, costly, and high‑stakes endeavor, often requiring more than ten years and enormous financial investment before a single therapy reaches the market. Breakthroughs in artificial intelligence and protein folding tools are now transforming this process by greatly enhancing how researchers interpret biological targets, craft potential drug molecules, and anticipate their effects. As these innovations advance, development timelines are shrinking, expenses are decreasing, and therapeutic possibilities once considered unattainable are becoming viable.The Essential Importance of Protein Architecture in Contemporary Drug DevelopmentMost medications exert their effects by attaching to specific proteins and modifying how those proteins…
